Doccla, a virtual ward and remote patient monitoring provider, has secured £335 million in Series B funding. The London-based company, featured on the HealthTech 50 ranking, plans to use the funds to strengthen its position in the UK and Ireland while expanding further in Europe, specifically targeting France and the DACH region. Currently, Doccla monitors patients in over 10 European countries and partners with the NHS in more than half its regions. Recently, it collaborated with the Irish government’s Health Service Executive. The funding round was led by Lakestar, with participation from Elaia, General Catalyst, Bertelsmann Investments, and Speedinvest. Oliver Heimes, a partner at Lakestar, will join Doccla’s board.
Doccla’s remote monitoring is enabled across 40 pathways, giving medical staff real-time access to patient data and alerting them to concerning signals before issues worsen, leading to in-person appointments.
“Doccla was founded to provide hospital-level care and support at home for multiple patient profiles across the acuity spectrum,” says founder Martin Ratz. “Technology-enabled virtual wards deliver great benefits for patients, who can recover at home, while freeing up resources for healthcare providers. Our work has proven immensely valuable to the UK’s National Health Service and we’re excited to scale our European operations. At the same time, we see exceptional upside potential for our services in the Life Sciences sector, and will continue to invest in our data science operations.” The company aims to maintain its top position in the UK while capitalizing on new markets and diversifying its offerings.
According to Heimes, “Remote patient care delivers proven results and is ushering in new standards in the healthcare system globally.”
